Nissui Pharmaceutical Co., Ltd. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nissui Pharmaceutical Co., Ltd. with three other
pharmaceutical manufacturers in Asia:
Ind-Swift Laboratories Limited
sales of 7.18 billion Indian Rupees [US$111.74 million]
Marksans Pharma Limited
(7.67 billion Indian Rupees [US$119.37 million]
Eris Lifesciences Ltd
based in India
(7.25 billion Indian Rupees [US$112.80 million]
of which 100%
During the year ended March of 2017, sales at
Nissui Pharmaceutical Co., Ltd. were ¥12.83 billion (US$114.53 million).
increase of 6.7%
versus 2016, when the company's sales were ¥12.02 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Nissui Pharmaceutical Co., Ltd. had sales
of ¥13.39 billion.
Sales of Industry Test Drug Business saw an increase
6.8% in 2017, from
¥2.94 billion to ¥3.14 billion.